Previous 10 | Next 10 |
Company Continues to Pursue Global Distribution Agreements During the "Home Stretch" in U.S. Based FDA Level Testing LOS ANGELES, CA / ACCESSWIRE / December 1, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leading manufacturer and worldwide distributo...
Data using XPRIZE supplied contrived fluid samples provides results comparable to those seen in the FDA lab testing of donor saliva, as DECN competes for the $5 million prize and GLOBAL validation LOS ANGELES, CA / ACCESSWIRE / November 23, 2020 / Decision Diagnostics Corp. (OTC PINK:DE...
With Favorable Testing Results Anticipated on November 13 From Our FDA and CLIA Certified Laboratory, DECN Estimates Completion and Filing of 3rd FDA EUA Application in the Next 3 Weeks LOS ANGELES, CA / ACCESSWIRE / November 12, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.de...
Company Being Sought Out Worldwide for Global Distribution Agreements as It Enters the "Home Stretch" in U.S.- Based Testing at FDA & CLIA Certified Lab LOS ANGELES, CA / ACCESSWIRE / November 6, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leadi...
Company Continues to Seek Global Distribution Agreements Across All Continents As It Makes Progress With Its U.S.- Based Testing at FDA & CLIA Certified Lab LOS ANGELES, CA / ACCESSWIRE / November 3, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a l...
Donor Study Activities Began, Friday October 16th at FDA and CLIA Certified Testing Lab; Data to Also Be Used for EU CE Mark and for Emergency Approval in the Russian Federation Countries LOS ANGELES, CA / ACCESSWIRE / October 19, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.d...
Includes International Distribution Status, Professional Video Finalized, XPRIZE Contest Next Steps, Manufacturing and Signed Testing Partner Updates LOS ANGELES, CA / ACCESSWIRE / October 13, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leadin...
LOS ANGELES, CA / ACCESSWIRE / October 5, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., the manufacturers and design specifiers for the :10.5 GenViro! Professional Swift Kit for Covid-19 testing, today announced that it has entered in...
Decision Diagnostics ([[DECN]] -3.9%), through its subsidiary Pharma Tech Solutions, received its first written purchase order from an Indian distributor.The order comprises of 500K GenViro! Saliva Swift Kits, 50K GenViro! Swift Verify Kits and 7.5K GenViro! Swift Kit Meters; several fol...
F irst Order From Indian Distributor Is Substantially Larger Than Expected, Exceeding International Launch Expectations With Follow-Up Orders From Distributors in Singapore and Malaysia Anticipated LOS ANGELES, CA / ACCESSWIRE / October 2, 2020 / Decision Diagnostics Corp. (OTC PINK:...
News, Short Squeeze, Breakout and More Instantly...
Decision Diagnostics Corp Company Name:
DECN Stock Symbol:
OTCMKTS Market:
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 7, 2021) - Faruqi & Faruqi, LLP, a leading national s...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 24, 2021) - If you suffered losses exceeding $300,000 investing ...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 20, 2021) - If you suffered losses exceeding $300,000 investing ...